Marshall W. Anderson - Publications

Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer.

Journal: Nature genetics

Published: October 08, 2020

Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer.

Journal: Cancer research

Published: September 24, 2020

Rare deleterious germline variants and risk of lung cancer.

Journal: NPJ precision oncology

Published: May 27, 2020

Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p, and 4q.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: July 25, 2019

Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 12, 2018

Genome-wide association study of familial lung cancer.

Journal: Carcinogenesis

Published: December 20, 2017

Parametric Linkage Analysis Identifies Five Novel Genome-Wide Significant Loci for Familial Lung Cancer.

Journal: Human heredity

Published: January 20, 2017

Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies.

Journal: Genes

Published: October 28, 2016

Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 21, 2015

A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.

Journal: Anti-cancer drugs

Published: February 04, 2015

A recurrent mutation in PARK2 is associated with familial lung cancer.

Journal: American journal of human genetics

Published: October 17, 2014

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer.

Journal: Clinical Medicine Insights. Oncology

Published: July 03, 2014